Meeting of the Chronic Fatigue Syndrome Advisory Committee, 14735-14736 [2017-05641]
Download as PDF
<![CDATA[
14735
Federal Register / Vol. 82, No. 54 / Wednesday, March 22, 2017 / Notices
ACTION:
Notice.
When
submitting comments or requesting
information, please include the
document identifier 0955–0009–60D for
reference.
Information Collection Request Title:
Customer Relationship Management
(CRM) Tool.
OMB No.: 0955–0009.
Abstract: The Customer Relationship
Management (CRM) application is a
nimble business intelligence tool being
used by more than 1,500 users at ONC
partner organizations and grantees. The
CRM collects data from a large number
of users throughout the United States
who are ‘‘on the ground’’ helping
healthcare providers adopt and optimize
their IT systems, it provides near realtime data about the adoption,
utilization, and meaningful use of EHR
technology. Approximately half of all
Primary Care Providers in the nation are
represented in the CRM tool; data points
SUPPLEMENTARY INFORMATION:
In compliance with the
Paperwork Reduction Act of 1995, the
Office of the Secretary (OS), Department
of Health and Human Services,
announces plans to submit an
Information Collection Request (ICR),
described below, to the Office of
Management and Budget (OMB). The
ICR is for extending the use of the
approved information collection
assigned OMB control number 0955–
0009 which expires on May 31, 2017.
Prior to submitting the ICR to OMB, OS
seeks comments from the public
regarding the burden estimate, below, or
any other aspect of the ICR.
SUMMARY:
Comments on the ICR must be
received on or before May 22, 2017.
DATES:
Submit your comments to
Information.CollectionClearance@
hhs.gov or by calling (202) 690–5683.
ADDRESSES:
include provider location, credential,
specialty, whether live on an EHR and
what system, whether they’ve reached
MU, the time between these, and
narrative barriers experienced by many
of these.
Need and Proposed Use of the
Information: The CRM tool supplements
and is regularly merged with other data
sources both within and outside of HHS
and tracks program performance and
progress towards milestones. Combined
with ONC’s internal analytical capacity,
this data provides feedback that goes
beyond anecdotal evidence and can be
turned into tangible lessons learned that
are used to focus policy and program
efforts and ultimately achieve concrete
outcomes.
Likely Respondents: HITECH
Grantees.
The total annual burden hours
estimated for this ICR are summarized
in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
CRM Tool—Workforce ......................................................................................................................
CRM Tool—Advance Interoperable HIE Program ............................................................................
CRM Tool—CHP/Academy Health ...................................................................................................
7
24
1
125
24
12
1.5
1.5
1.5
1,313
864
18
Total ...........................................................................................................................................
32
161
4.5
2,195
OS specifically requests comments on
(1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Terry S. Clark,
Asst. Information Collection Clearance
Officer.
[FR Doc. 2017–05627 Filed 3–21–17; 8:45 am]
BILLING CODE 4150–45–P
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (DHHS) is hereby giving notice
that a webinar meeting of the Chronic
Fatigue Syndrome Advisory Committee
(CFSAC) will take place and will be
open to the general public to listen in
via a toll free number.
DATES: The CFSAC webinar will be held
on Thursday, June 29, 2017, from 12
p.m. until 5 p.m. (EST) and on Friday,
June 30, 2017 from 9 a.m. to 5 p.m.
ADDRESSES: This meeting will be
broadcasted to the public as a webinar.
A webinar is a virtual meeting.
Registration is not required for the
webinar.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Chronic Fatigue
Syndrome Advisory Committee
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
VerDate Sep<11>2014
18:14 Mar 21, 2017
Jkt 241001
Gustavo Seinos, MPH, Designated
Federal Officer, Chronic Fatigue
Syndrome Advisory Committee,
Department of Health and Human
Services, 200 Independence Avenue
SW., Room 728F.6, Washington, DC
20201. Please direct all inquiries to
cfsac@hhs.gov.
SUPPLEMENTARY INFORMATION: The
CFSAC is authorized under 42
U.S.C.217a, Section 222 of the Public
Health Service Act, as amended. The
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
purpose of the CFSAC is to provide
advice and recommendations to the
Secretary of Health and Human Services
(HHS), through the Assistant Secretary
for Health (ASH), on issues related to
myalgic encephalomyelitis/chronic
fatigue syndrome (ME/CFS). The issues
can include factors affecting access and
care for persons with ME/CFS; the
science and definition of ME/CFS; and
broader public health, clinical, research,
and educational issues related to
ME/CFS.
The agenda for this meeting, call-in
information and location will be posted
on the CFSAC Web site https://
www.hhs.gov/ash/advisory-committees/
cfsac/meetings/.
A half hour of public comment via
telephone will be scheduled for the first
half day of the webinar and an entire
hour for the second day of the webinar.
Individuals will have five minutes to
present their comments. Priority will be
given to individuals who have not
provided public comment within the
previous year. We are unable to place
international calls for public comments.
To request a time slot for public
comment, please send an email to
cfsac@hhs.gov by June 1, 2017. The
email should contain the speaker’s
E:\FR\FM\22MRN1.SGM
22MRN1
14736
Federal Register / Vol. 82, No. 54 / Wednesday, March 22, 2017 / Notices
name and the phone number that will
be used for public comment.
Individuals who would like for their
testimony to be provided to the
Committee members should submit a
copy of the testimony prior to the
meeting. It is preferred, but not
required, that the submitted testimony
be prepared in digital format and typed
using a 12-pitch font. Copies of the
written comment must not exceed 5
single-space pages, and it is preferred,
but not required that the document be
prepared in the MS Word format. Please
note that PDF files, handwritten notes,
charts, and photographs cannot be
accepted. Materials submitted should
not include sensitive personal
information, such as social security
number, birthdates, driver’s license
number, passport number, financial
account number, or credit or debit card
number. If you wish to remain
anonymous the document must specify
this.
The Committee welcomes input on
any topic related to ME/CFS.
Dated: March 2, 2017.
Gustavo Seinos,
Commander, USPHS, Designated Federal
Officer.
Dated: March 16, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–05641 Filed 3–21–17; 8:45 am]
BILLING CODE 4150–42–P
[FR Doc. 2017–05586 Filed 3–21–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
asabaliauskas on DSK3SPTVN1PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Limited Interaction Targeted
Epidemiology (LITE) to Advance HIV
Prevention (UG3/UH3).
Date: April 19–20, 2017.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
VerDate Sep<11>2014
18:14 Mar 21, 2017
Jkt 241001
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Audrey Oi-ting Lau, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, MSC–9823, Rockville, MD
20852, 240–669–2081.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID; Peer Review Meeting.
Date: April 20, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Dharmendar Rathore,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3G30, National
Institutes of Health/NIAID, 5601 Fishers
Lane, Drive, MSC 9823, Bethesda, MD
20892–9823, 240–669–5058, rathored@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, March
28, 2017, 08:00 a.m. to March 29, 2017,
01:00 p.m., Hyatt Regency Bethesda,
One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814
which was published in the Federal
Register on December 13, 2016, 81 FR
89954.
The meeting notice is amended to
change the meeting dates to May 1–2,
2017. The location and time will remain
the same. The meeting is closed to the
public.
Dated: March 16, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–05584 Filed 3–21–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Molecular Probes and Tools for
Studying the Nervous System.
Date: March 30, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Peter B Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel.
Member Conflict: Topics in Nephrology.
Date: April 3, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jonathan K Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040A,
MSC 7806, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel.
Member Conflict: Topics in Hepatology.
Date: April 4, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 82, Number 54 (Wednesday, March 22, 2017)]
[Notices]
[Pages 14735-14736]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05641]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Chronic Fatigue Syndrome Advisory Committee
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services (DHHS) is hereby giving notice
that a webinar meeting of the Chronic Fatigue Syndrome Advisory
Committee (CFSAC) will take place and will be open to the general
public to listen in via a toll free number.
DATES: The CFSAC webinar will be held on Thursday, June 29, 2017, from
12 p.m. until 5 p.m. (EST) and on Friday, June 30, 2017 from 9 a.m. to
5 p.m.
ADDRESSES: This meeting will be broadcasted to the public as a webinar.
A webinar is a virtual meeting. Registration is not required for the
webinar.
FOR FURTHER INFORMATION CONTACT: Gustavo Seinos, MPH, Designated
Federal Officer, Chronic Fatigue Syndrome Advisory Committee,
Department of Health and Human Services, 200 Independence Avenue SW.,
Room 728F.6, Washington, DC 20201. Please direct all inquiries to
cfsac@hhs.gov.
SUPPLEMENTARY INFORMATION: The CFSAC is authorized under 42 U.S.C.217a,
Section 222 of the Public Health Service Act, as amended. The purpose
of the CFSAC is to provide advice and recommendations to the Secretary
of Health and Human Services (HHS), through the Assistant Secretary for
Health (ASH), on issues related to myalgic encephalomyelitis/chronic
fatigue syndrome (ME/CFS). The issues can include factors affecting
access and care for persons with ME/CFS; the science and definition of
ME/CFS; and broader public health, clinical, research, and educational
issues related to ME/CFS.
The agenda for this meeting, call-in information and location will
be posted on the CFSAC Web site https://www.hhs.gov/ash/advisory-committees/cfsac/meetings/.
A half hour of public comment via telephone will be scheduled for
the first half day of the webinar and an entire hour for the second day
of the webinar. Individuals will have five minutes to present their
comments. Priority will be given to individuals who have not provided
public comment within the previous year. We are unable to place
international calls for public comments. To request a time slot for
public comment, please send an email to cfsac@hhs.gov by June 1, 2017.
The email should contain the speaker's
[[Page 14736]]
name and the phone number that will be used for public comment.
Individuals who would like for their testimony to be provided to
the Committee members should submit a copy of the testimony prior to
the meeting. It is preferred, but not required, that the submitted
testimony be prepared in digital format and typed using a 12-pitch
font. Copies of the written comment must not exceed 5 single-space
pages, and it is preferred, but not required that the document be
prepared in the MS Word format. Please note that PDF files, handwritten
notes, charts, and photographs cannot be accepted. Materials submitted
should not include sensitive personal information, such as social
security number, birthdates, driver's license number, passport number,
financial account number, or credit or debit card number. If you wish
to remain anonymous the document must specify this.
The Committee welcomes input on any topic related to ME/CFS.
Dated: March 2, 2017.
Gustavo Seinos,
Commander, USPHS, Designated Federal Officer.
[FR Doc. 2017-05641 Filed 3-21-17; 8:45 am]
BILLING CODE 4150-42-P
